M. Iwasaki
- Pharmacology top 0.05%
- Pharmacogenetics and Drug Metabolism 21
-
- Quantum Chromodynamics and Particle Interactions 33
- Particle physics theoretical and experimental studies 29
- Nuclear physics research studies 16
- Biochemistry top 1%
- Cancer Research top 5%
- Oncology top 5%
-
- Muon and positron interactions and applications 38
-
- Atomic and Molecular Physics 22
- Quantum, superfluid, helium dynamics 22
- Atomic and Subatomic Physics Research 13
- Co-authors
- F. Peter GuengerichDong‐Hyun KimFred F. KadlubarMarguerite A. ButlerMehmet Akif SariR. HayanoMasahiko NegishiWilliam R. Brian
- Journals
- Nature (1 paper)Proceedings of the National Academy of Sciences (1 paper)Physical Review Letters (10 papers)
- Partner nations
- JapanUnited StatesGermany
In The Last Decade
M. Iwasaki
165 papers receiving 5.6k citations
Hit Papers
Peers
Comparison fields: 5 of 160
- Pharmacology 1.9k
- Nuclear and High Energy Physics 1.2k
- Biochemistry 317
- Cancer Research 532
- Oncology 928
Countries citing papers authored by M. Iwasaki
This map shows the geographic impact of M. Iwasaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Iwasaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Iwasaki more than expected).
Fields of papers citing papers by M. Iwasaki
This network shows the impact of papers produced by M. Iwasaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Iwasaki. The network helps show where M. Iwasaki may publish in the future.
Co-authorship network
The 25 scholars most cited alongside M. Iwasaki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 2 | |
| 2 | 2023 | 0 | |
| 3 | 2022 | 3 | |
| 4 | 2018 | 82 | |
| 5 | 2017 | 22 | |
| 6 | 2014 | 23 | |
| 7 | 2008 | 18 | |
| 8 | 2004 | 95 | |
| 9 | 2003 | 6 | |
| 10 | Observation of Kaonic Hydrogen X-rays | 1997 | 0 |
| 11 | 1997 | 2 | |
| 12 | 1994 | 5 | |
| 13 | 1992 | 11 | |
| 14 | 1991 | 3 | |
| 15 | 1991 | 22 | |
| 16 | 1991 | 16 | |
| 17 | 1990 | 183 | |
| 18 | 1988 | 1 | |
| 19 | Search for Heavy Neutrinos in Kaon Decay | 1984 | 19 |
| 20 | A NEW IMPROVED EXPERIMENT TO SEARCH FOR HEAVY NEUTRINOS AND NEUTRAL BOSONS IN KAON DECAY | 1984 | 1 |
About M. Iwasaki
M. Iwasaki is a scholar working on Nuclear and High Energy Physics, Pharmacology and Atomic and Molecular Physics, and Optics, having authored 173 papers that have together received 5.8k indexed citations. Recurring topics across this work include Muon and positron interactions and applications (38 papers), Quantum Chromodynamics and Particle Interactions (33 papers), Particle physics theoretical and experimental studies (29 papers), Atomic and Molecular Physics (22 papers), Quantum, superfluid, helium dynamics (22 papers), Pharmacogenetics and Drug Metabolism (21 papers), Nuclear physics research studies (16 papers) and Atomic and Subatomic Physics Research (13 papers). The work is most often cited by research in Pharmacology (1.9k citations), Nuclear and High Energy Physics (1.2k citations) and Biochemistry (317 citations). M. Iwasaki has collaborated with scholars based in Japan, United States and Germany. Frequent co-authors include F. Peter Guengerich, Dong‐Hyun Kim, F. Peter Guengerich, Fred F. Kadlubar, Marguerite A. Butler, Mehmet Akif Sari, R. Hayano, Masahiko Negishi, William R. Brian and Risto O. Juvonen. Their work appears in journals such as Nature, Proceedings of the National Academy of Sciences and Physical Review Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.